Fitbit for Thoracic Diseases
Geriatric Thoracic Surgery Ambulation Challenge
See full descriptionAbout the trial for Thoracic Diseases
Treatment Groups
This trial involves 2 different treatments. Fitbit is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
About The Treatment
Eligibility
This trial is for patients born any sex aged 65 and older. There are 2 eligibility criteria to participate in this trial as listed below.
Approximate Timelines
Measurement Requirements
This trial is evaluating whether Fitbit will improve 4 primary outcomes in patients with Thoracic Diseases. Measurement will happen over the course of 1 week.
Who is running the study
Principal InvestigatorPatient Q & A Section
What are common treatments for thoracic diseases?
The management of thoracic diseases may involve medication, physical therapy, diagnostic procedures, or surgery. Some thoracic disorders have treatment modalities that are common, while other abnormalities may have other treatments.
What is thoracic diseases?
Thoracic disorders are often overlooked by medical practitioners, and, if detected, were often missed if their clinical presentation was non-specific; however, more often they pose a diagnostic and therapeutic dilemma. Symptoms can be variable, and differential diagnoses of thoracic diseases must be considered in order to exclude the possibility of an incorrect diagnosis and the unnecessary need for surgical intervention in the form of surgery, thoracotomy, or video-assisted thoracoscopy to be performed. The symptoms of an interstitial lung disease and the associated disorders can be very similar.
What causes thoracic diseases?
Pneumothorax and empyema are the most common lung disorders of children found at autopsy. The leading causes of respiratory disease during the study period were gastroesophageal reflux disease (GERD), upper respiratory infections, and congenital anomalies.
How many people get thoracic diseases a year in the United States?
The United States has the highest occurrence of thoracic diseases in the world; they were responsible for more than 15% of all neoplastic and nonneoplastic deaths in American men in 2006. For these reasons, the U.S. must continue to emphasize prevention methods of major thoracic diseases.
What are the signs of thoracic diseases?
Thoracic diseases are uncommon conditions with nonspecific clinical signs. They may present with a constellation of nonspecific symptoms and signs which can obscure their diagnosis.
Can thoracic diseases be cured?
There is no way to cure thoracic diseases (except in the case of an operation), but patients need not be afraid if they know their physical condition can be improved with modern medical treatment.
Has fitbit proven to be more effective than a placebo?
We found no statistically significant difference between the relative performance of fitness equipment (Fitbit vs. placebo) in people with chronic cough, but there is a trend for those on fitness equipment to achieve benefits sooner that those on a placebo. However, given the potential health benefits, further work is required to explore the mechanisms and impact of the devices in the treatment of people with cough.
Who should consider clinical trials for thoracic diseases?
For thoracic diseases, clinical trial eligibility criteria can be used to identify patients with a high likelihood of benefit from enrollment in a thoracic surgery trial.
How serious can thoracic diseases be?
Most patients had some symptoms. Few of them were life-threatening. A small number of patients had complications of their disease. Most patients had the same symptom for a long time with moderate symptoms. A lot of these patients was misdiagnosed.
Have there been other clinical trials involving fitbit?
A few studies have looked at the effect of wearable devices such as the FitBit on physiological parameters pertinent to physical activity. As many of these studies show that the use of wearable monitoring devices such as the Fitbit does not have an effect on daily physical activity level or body composition, there is the possibility that the findings are specific to the test population or conditions included. Further experimentation is needed to confirm whether there is a real effect in the general population.
Does fitbit improve quality of life for those with thoracic diseases?
In patients with thoracic diseases, the use of Fitbit, a mobile and web-based pedometer, led to improvement of weight, BMI, and physical fitness and to an overall improvement in HRQL, especially for the activity-related aspects of HRQL.